Nexstim Plc signs an Independent Selling Representative Agreement in the US with JTec Surgical

Helsinki, Finland: 22 March 2017 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new Independent Selling Representative Agreement in the US with JTec Surgical, Inc. to represent the Nexstim Brain Mapping (NBS) system. The NBS system is used for the pre-surgical mapping of the speech and motor cortices of the brain.

JTec Surgical will cover the Southern California region, where it has established a strong presence and relationships in the neurosurgical technology space for more than 25 years. The JTec portfolio includes a number of carefully selected and innovative products for neurosurgical procedures.

More info on Nexstim's website.


Next > Mainstay Medical Publishes 2016 Full Year Results and Business Update

Previous > Avantium raises 103 million in successful Initial Public Offering